mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.02 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.061 |
0.03 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.03 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.04 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.04 |